Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
VBI Vaccines Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
VBI Vaccines Inc, Medical Devices Deals, 2012 to YTD 2018 10
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deal Details 13
Venture Financing 13
Variation Biotech Raises US$1.5 Million In Venture Financing 13
Variation Biotech Raised US$1.4 Million In Venture Financing 14
Variation Biotech Raises US$0.25 Million In Venture Financing 15
Variation Biotech Raises US$0.8 Million In Venture Financing 16
Variation Biotech Raises Additional US$1.2 Million In Venture Financing 17
VBI Vaccines Inc – Key Employees 19
VBI Vaccines Inc – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Financial Announcements 21
Jul 26, 2018: VBI Vaccines Announces Second Quarter 2018 Financial Results and Provides Corporate Update 21
May 01, 2018: VBI Vaccines Reports First Quarter 2018 Financial Results 23
Corporate Communications 25
Sep 26, 2018: VBI Vaccines announces formation of new scientific and clinical advisory boards 25
Aug 15, 2018: VBI Vaccines appoints Christopher McNulty as chief financial officer and head of business development 27
Mar 12, 2018: VBI Vaccines Announces Voluntary Delisting from the Toronto Stock Exchange 28
Jan 26, 2018: VBI Vaccines Announces Changes to its Board of Directors 29
Nov 02, 2017: VBI Vaccines Strengthens Board of Directors with Appointment of Ran Nussbaum 30
Government and Public Interest 31
May 31, 2017: Researchers Explore the Possible Link between CMV Infection, Obesity, and Metabolic Syndrome 31
Product News 32
11/10/2017: VBI Vaccines to Present New Preclinical Data for its GBM Immunotherapy, VBI-1901, at SITC 2017 32
04/17/2018: VBI Vaccines Announces Positive DSMB Review in Phase 1/2a Study of VBI-1901 in Recurrent Glioblastoma (GBM) Patients 33
04/05/2017: VBI Vaccines to Present Update on VBI-1901 at the World Vaccine Congress 34
02/07/2017: VBI Vaccines Receives Positive EMA Scientific Advice Regarding Sci-B-Vac Phase III Clinical Study 35
01/17/2018: VBI Vaccines Announces Dosing of First GBM Patient in Phase 1/2a Clinical Study of VBI-1901 36
Product Approvals 37
Aug 15, 2017: VBI Vaccines Announces FDA Acceptance of Investigational New Drug Application for VBI-1901 to Treat Glioblastoma Multiforme 37
Clinical Trials 38
Oct 11, 2017: VBI Vaccines to Present Phase 1 CMV vaccine data at The World Vaccine Congress Europe 2017 in Barcelona 38
Oct 11, 2017: VBI Vaccines to Present preclinical Zika vaccine data at The World Vaccine Congress Europe 2017 in Barcelona 39
Aug 28, 2017: VBI Vaccines to Present New Preclinical Data for its GBM Immunotherapy, VBI-1901, at The Immuno-Oncology Summit 40
Jul 27, 2017: VBI Vaccines Announces Positive Interim Data from Phase 1 Study of Preventative CMV Vaccine 41
May 02, 2017: VBI Vaccines Provides Update on its Congenital CMV Phase I Clinical Study 42
Feb 22, 2017: VBI Vaccines Receives Positive Response from Health Canada’s Initial Evaluation of the Proposed Sci-B-Vac Phase III Clinical Program 43
Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
VBI Vaccines Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
VBI Vaccines Inc, Deals By Therapy Area, 2012 to YTD 2018 9
VBI Vaccines Inc, Medical Devices Deals, 2012 to YTD 2018 10
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Variation Biotech Raises US$1.5 Million In Venture Financing 13
Variation Biotech Raised US$1.4 Million In Venture Financing 14
Variation Biotech Raises US$0.25 Million In Venture Financing 15
Variation Biotech Raises US$0.8 Million In Venture Financing 16
Variation Biotech Raises Additional US$1.2 Million In Venture Financing 17
VBI Vaccines Inc, Key Competitors 18
VBI Vaccines Inc, Key Employees 19
VBI Vaccines Inc, Other Locations 20
VBI Vaccines Inc, Subsidiaries 20
List of Figures
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
VBI Vaccines Inc, Medical Devices Deals, 2012 to YTD 2018 10